An underdiagnosed type of diabetes: The MODY syndromes. Pathophysiology, clinical presentation and renal disease progression

Journal of Nephrology

Volumn 17, Issue 5, 2004, Pages 637-641

  Tsakiris, Dimitrios ^a   Ioannou, Kyriakos ^a  

^a GENERAL HOSPITAL OF VERIA   (Greece)

Author keywords

Diabetic complications; Early onset diabetes; Glucokinase; HNF 1 ; HNF 1 ; HNF 4 ; IPF 1; MODY syndrome; NeuroD BETA2

Indexed keywords

GLUCOKINASE; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; NEUROGENIC DIFFERENTIATION FACTOR; NUCLEAR FACTOR I;

AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOMAL LOCALIZATION; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE COURSE; EARLY DIAGNOSIS; FAMILY HISTORY; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC COUNSELING; GENETIC HETEROGENEITY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MATURITY ONSET DIABETES MELLITUS; MICROALBUMINURIA; MICROANGIOPATHY; NEUROPATHY; NONHUMAN; ONSET AGE; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RENOVASCULAR HYPERTENSION; RETINOPATHY; REVIEW; RISK FACTOR; UNITED STATES; ADULT; CHILD; NON INSULIN DEPENDENT DIABETES MELLITUS; SYNDROME;

ADULT; AGE OF ONSET; CHILD; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; SYNDROME;

EID: 16644385273     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Winter WE, Nakamura M, House DV. Monogenic diabetes mellitus in youth. The MODY syndromes. Endocrinol Metab Clin North Am 1999; 28: 765-85.
2. Fajans S, Bell G, Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity onset diabetes of the young. N Engl J Med 2001; 345: 971-80.
3. Hattersley AT, Tattersall RB. Maturity onset diabetes of the young. In Pickup J, William G (Eds). Textbook of diabetes (2nd edn). Oxford: Blackwell 1997. 22. 1-10.
4. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328: 697-702.
5. Ledermann HM. Maturity onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? Diabetologia 1995; 38: 1482.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 (suppl): S5-10.
7. Hattersley AT. Maturity onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 1998; 15: 15-24.
8. Polonski KS. The β-cell in diabetes: From molecular genetics to clinical research. Diabetes 1995; 44: 705-17.
9. Fajans SS, Brown MB. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity onset diabetes of the young. Diabetes Care 1993; 16: 1254-61.
10. Velho G, Froguel P. Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol 1998; 138: 233-9.
11. Clement K, Pueyo ME, Vaxillaire M, Rakotoambinina B, Thuillier F, Passa P, Froguel P, Robert JJ, Vello G. Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia 1996; 39: 82-90.
12. Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes. Diabetes 1990; 39: 647-52.
13. Byrne MM, Sturis J, Clement K. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994; 93: 1120-30.
14. Woolf AS. Diabetes, genes and kidney development. Kidney Int 2000; 57: 1202-3.
15. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 1996; 84: 575-85.
16. Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S, Sarelin L, Haggblom M, Groop L. Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 1998; 41: 467-73.
17. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care 1996; 19: 915-9.
18. Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T, Berry P, Clark P, Linder T, Bell G, Ryffel GU, Nicholls A, Hattersley A. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int 2000; 5: 898-907.
19. Bingham C, Bulman MP, Ellard S, Allen LI, Lipkin GW, Hoff WG, Woolf AS, Rizzoni G, Novelli G, Nicholls AJ, Hattersley AT. Mutations in the hepatocyte nuclear factor-1 beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 2001; 68: 219-24.
20. Marsich E, Vetere A, Di Piazza M, Tell G, Paoletti S. The PAX6 gene is activited by the basic helix-loop-helix transcription factor NeuroD/BETA2. Biochem J 2003; 376: 707-15.
21. Kristinsson SY, Thorolfsdottir ET, Talseth B, Steingrimsson E, Thorsson AV, Helgason T, Hreidarsson AB, Arngrimsson R. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. Diabetologia 2001; 44: 2098-103.
22. Marsich E, Vetere A, Piazza Di M, Tell G, Paoletti S. The PAX6 gene is activated by the basic helix-loop-helix transcription factor NeuroD/BETA2. Biochem J 2003; 37: 6707-15.
23. Naya F, Huang H, Qiu Y, Mutoh H, DeMayo F, Leiter A, Tsai M. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/NeuroD-deficient mice. Genes Dev 1997; 11: 2323-34.
24. Frayling T, Lindgren C, Chevre J, Menzel S, Wishart M, Benmezroua Y, Brown A, Evans JC, Rao PS, Dina C, Lecocur C, Kanninen T, Almgren P, Bulman MP, Wang Y, Mills J, Wright-Pascoe R, Mahtani MM, Prisco F, Costa A, Cognet I, Hansen T, Pedersen O, Ellard S, Tuomi T, Groop LC, Froguel P, Hattersley AT, Vaxillaire M. A genome-wide scan in families with maturity-onset diabetes of the young. Evidence for further genetic heterogeneity. Diabetes 2003; 52: 872-81.
25. Lindgren C, Widén E, Tuomi T, Li H, Almgren P, Kanninen T, Melander O, Weng J, Lehto M, Groop LC. Contribution of known and unknown susceptibility genes to early-onset diabetes in Scandinavia. Evidence for heterogeneity. Diabetes 2002; 51: 1609-17.
26. Laasko M, Pyorala K. Age of onset and type of diabetes. Diabetes Care 1985; 8: 114-7.
27. Lee SC, Ko GT, Li JK, Chow CC, Yeung VT, Critchley JA, Cockram CS, Chan JC. Factors predicting the age when type 2 diabetes is diagnosed in Hong Kong Chinese subjects. Diabetes Care 2001; 24: 646-9.
28. Doria A, Yang Y, Malecki M, Scotti S, Dreyfus J, O'Keeffe C, Orban T, Warram JH, Krolewski AS. Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes. Diabetes Care 1999; 22: 253-61.
29. Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, Uchigata Y, Omori Y. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 1997; 20: 844-7.
30. Yamada S, Nishigori H, Onda H, Utsugi T, Yanagawa T, Maruyama T, Onigata K, Nagashima K, Nagai R, Morikawa A, Takeuchi T, Takeda J. Identification of mutations in the hepatocyte nuclear factor (HNF)-1α gene Japanese subjects with IDDM. Diabetes 1997; 46: 1643-7.
31. Moller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O. Mutations in the hepatocyte nuclear factor lot gene in Caucasian families originally classified as having type I diabetes. Diabetologia 1998; 41: 1528-31.
32. Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care 1990; 13: 49-64.